Autopsy report · NCT01769443

Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation

“Inability to enroll within funding period”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 1 month before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Sponsor type

US National Institutes of Health

Conditions

Primary Heart Transplant; Heart Transplantation; Heart Transplant

Interventions

bortezomib; plasmapheresis

Participants

2

Sites

14

Countries

United States

Trials that died the same way

• BREATHE-Easy Trial
  “Funding completion date passed, inadequate enrollment” (78% match in meaning)
• Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women
  “Funding ended before enrollment” (76% match in meaning)
• Medical Therapies for Chronic Post-Traumatic Headaches
  “inadequate enrollment, insufficient funds to continue enrollment” (75% match in meaning)
• Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia
  “Loss of funding before enrollment.” (75% match in meaning)
• Vitamine D Treatment in Chronic Heart Failure
  “financial reasons / insufficient enrollment activity” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.